• Yaqing Shu, Wei Qiu, Junfeng Zheng, Xiaobo Sun, Junping Yin, Xiaoli Yang, Xiaoyang Yue, Chen Chen, Zhihui Deng, Shasha Li, Yu Yang, Fuhua Peng, Zhengqi Lu, Xueqiang Hu, Frank Petersen, and Xinhua Yu.
• Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
• J. Neurol. Neurosurg. Psychiatr. 2019 Jun 1; 90 (6): 652-658.

Background And ObjectiveAetiology and pathogenesis of anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis, the most common autoimmune encephalitis, is largely unknown. Since an association of the disease with the human leucocyte antigen (HLA) has not been shown so far, we here investigated whether anti-NMDAR encephalitis is associated with the HLA locus.MethodsHLA loci of 61 patients with anti-NMDAR encephalitis and 571 healthy controls from the Chinese Han population were genotyped and analysed for this study.ResultsOur results show that the DRB1*16:02 allele is associated with anti-NMDAR encephalitis (OR 3.416, 95% CI 1.817 to 6.174, p=8.9×10-5, padj=0.021), with a higher allele frequency in patients (14.75%) than in controls (4.82%). This association was found to be independent of tumour formation. Besides disease susceptibility, DRB1*16:02 is also related to the clinical outcome of patients during treatment, where patients with DRB1*16:02 showed a lower therapeutic response to the treatment than patients with other HLA alleles (p=0.033). Bioinformatic analysis using HLA peptide-binding prediction algorithms and computational docking suggested a close relationship between the NR1 subunit of NMDAR and the DRB1*16:02.ConclusionsThis study for the first time demonstrates an association between specific HLA class II alleles and anti-NMDAR encephalitis, providing novel insights into the pathomechanism of the disease.© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

20 keywords...

hide…